Related Experiment Videos
Lupus nephritis: update on pathogenesis and disease mechanisms
1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.
Seminars in Nephrology
|April 7, 1999
Summary
Systemic lupus erythematosus (SLE) can cause immune-mediated nephritis through diverse mechanisms. Understanding autoantibodies and immune cell recruitment offers new therapeutic targets for kidney disease in SLE patients.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Immune-mediated nephritis is a frequent complication of systemic lupus erythematosus (SLE).
- The heterogeneity in SLE pathogenesis arises from multiple, independent contributing mechanisms.
- Research has identified key autoantibodies, cellular effectors, and soluble immune factors driving renal injury.
Purpose of the Study:
- To elucidate the complex immunologic interactions underlying renal immune injury in SLE.
- To characterize the mechanisms of autoantibody localization and immune cell recruitment in the kidney.
- To identify novel therapeutic targets for autoimmune nephritis in SLE.
Main Methods:
- Characterization of disease-relevant autoantibodies.
- Analysis of cellular effectors, including macrophages and T cells.
- Investigation of soluble immune elements like growth factors and cytokines.
Main Results:
- Diverse autoantibodies localize to the kidney via multiple mechanisms.
- Activated macrophages and T cells are recruited to the kidney.
- Abnormal production of growth factors and cytokines contributes to immune cell recruitment.
Conclusions:
- Multiple pathways contribute to the pathogenesis of lupus nephritis.
- Nephritogenic autoantibodies and immune cell infiltration are key drivers of kidney damage.
- Targeting these immune pathways offers potential for treating SLE-associated nephritis.